Wave life sciences ltd. (WVE)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Revenue

4,161

2,400

2,929

7,628

3,026

3,620

4,493

4,879

1,422

1,098

1,315

1,097

383

-

392

417

-

0

0

126

26

Operating expenses:
Research and development

41,158

49,128

44,585

41,605

40,113

39,809

32,876

32,547

29,196

25,369

20,097

19,103

14,740

13,995

13,686

8,401

4,736

3,468

2,132

1,850

1,607

General and administrative

12,996

13,805

12,523

11,640

10,901

12,754

9,849

8,905

8,001

6,887

7,571

6,667

5,850

5,185

3,939

3,654

3,216

3,746

2,858

1,905

1,884

Total operating expenses

54,154

62,933

57,108

53,245

51,014

52,563

42,725

41,452

37,197

32,256

27,668

25,770

20,590

19,180

17,625

12,055

7,952

7,214

4,990

3,755

3,491

Loss from operations

-49,993

-60,533

-54,179

-45,617

-47,988

-48,943

-38,232

-36,573

-35,775

-31,158

-26,353

-24,673

-20,207

-18,897

-17,233

-11,638

-7,952

-7,214

-4,990

-3,629

-3,465

Other income, net:
Dividend income

385

736

1,208

1,544

1,424

1,014

1,064

934

356

291

515

482

290

-

-

-

-

-

-

-

-

Interest income, net

3

4

6

8

11

6

5

4

7

1

1

1

3

9

118

106

104

-

25

-15

-

Other income (expense), net

2,112

3,023

2,239

2,123

2,353

9,933

-468

-259

343

-120

-75

-64

-72

-25

-36

15

-4

-99

112

-7

50

Total other income, net

2,500

3,763

3,453

3,675

3,788

10,953

601

679

706

172

441

419

221

239

82

121

100

-23

137

-22

50

Loss before income taxes

-47,493

-56,770

-50,726

-41,942

-44,200

-37,990

-37,631

-35,894

-35,069

-30,986

-25,912

-24,254

-19,986

-18,658

-17,151

-11,517

-7,852

-7,237

-4,853

-3,651

-3,415

Income tax provision

0

0

0

0

0

-103

0

0

172

-193

-418

343

1,110

55

384

48

-5

-138

83

49

50

Net loss

-47,493

-56,770

-50,726

-41,942

-44,200

-37,887

-37,631

-35,894

-35,241

-30,793

-25,494

-24,597

-21,096

-18,713

-17,535

-11,565

-7,847

-7,099

-4,936

-3,700

-3,465

Net loss per share attributable to ordinary shareholders—basic and diluted

-1.38

-1.66

-1.48

-1.22

-1.36

-1.29

-1.28

-1.23

-1.26

-1.12

-0.92

-0.91

-0.90

-0.82

-0.75

-0.51

-0.36

-0.47

-0.54

-0.40

-0.42

Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders—basic and diluted

34,461

34,327

34,281

34,260

32,597

29,484

29,333

29,144

27,919

27,863

27,758

26,899

23,531

23,497

23,445

22,708

21,551

15,285

9,223

9,223

8,273

Other comprehensive income (loss):
Net loss

-47,493

-56,770

-50,726

-41,942

-44,200

-37,887

-37,631

-35,894

-35,241

-

-25,494

-

-

-

-

-

-

-

-

-

-

Foreign currency translation

6

-15

2

30

97

-28

-20

36

49

388

1

3

15

-

-

-

-

-

-

-

-

Comprehensive loss

-47,487

-56,785

-50,724

-41,912

-44,103

-37,915

-37,651

-35,858

-35,192

-30,405

-25,493

-24,594

-21,081

-

-

-

-

-

-

-

-